Trial finds experimental chikungunya vaccine CHIKV VLP is safe

A Phase 2 trial by the National Institute of Allergy and Infectious Diseases (NIAID) of an experimental chikungunya vaccine has been found to be safe and well-tolerated, producing durable immune responses in healthy volunteers. Detailed […]